A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1)
Open Access
- 4 December 2019
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (6), 1541-1550
- https://doi.org/10.1016/j.vaccine.2019.11.059
Abstract
No abstract availableKeywords
Funding Information
- Biomedical Advanced Research and Development Authority
This publication has 20 references indexed in Scilit:
- A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) VaccinePLOS ONE, 2012
- Vaccines for Pandemic Influenza: Summary of Recent Clinical TrialsPublished by Springer Science and Business Media LLC ,2009
- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly AdultsPLOS ONE, 2009
- Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and childrenVaccine, 2008
- Increased sensitivity for detecting avian influenza-specific antibodies by a modified hemagglutination inhibition assay using horse erythrocytesJournal of Virological Methods, 2008
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell CultureNew England Journal of Medicine, 2008
- Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialThe Lancet, 2006
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- Human influenza A H5N1 virus related to a highly pathogenic avian influenza virusThe Lancet, 1998
- An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccinesJournal of Biological Standardization, 1977